Replies to post #155689 on Biotech Values

[jq1234]

Most of these tie-up happened at a time when they were not expected. Those expected tie-up between partners rarely happened!

[DewDiligence]

Buyouts of Biotech Partners

This is a subset of the “Recent Biotech Buyouts” table that resides in the
introductory section of the Biotech Values board under the Tables heading.
This table is not intended to be exhaustive.

Table entries are in descending order of buyout premium.

 
 Acquired                       Winning   iHub           
 Company  Buyer  Premium  Date  Bidder  Reference 
 GNLB     GSK     465%   10/08          #msg-33209281 
 MEMY     Roche   319%   11/08          #msg-33787598 
 COLY     PFE     167%   11/07          #msg-24600805 
 ICGN     PFE     150%    7/11          #msg-65365128 
 SGXP     LLY     119%    7/08          #msg-30547648 
 ENCY     PFE     118%    2/08          #msg-26978155 
 HGSI     GSK      99%    7/12          #msg-77532608 
 Speedel  NVS      94%    7/08          #msg-30588524 
 MEDX     BMY      90%    7/09          #msg-39801273 
 ZGEN     BMY      84%    9/10          #msg-54152162 
 FACT     BIIB‡    64%    3/10  ABT     #msg-47606240 
 MAPP     AGN      60%    1/13          #msg-83696395 
 CRXL     JNJ      58%   12/10          #msg-57504349 
 TNOX     DNA      50%   11/06          #msg-14673162 
 ICOS     LLY      25%   12/06          #msg-15623908 
 ABGX     AMGN     54%   12/05          #msg-8876857 
 IMCL     BMY‡     51%   10/08  LLY     #msg-32662830 
 SGP      MRK      34%    3/09          #msg-36140327 
 MITI     AMGN     33%    1/12          #msg-71341339

‡Spurned offer; premium and date are for winning bidder.